Gabrielle M. Etzel

Pittsburgh, United States

Healthcare Reporter at Washington Examiner

Articles

Trump HHS pick Jim O'Neill favors more anti-aging research

6 days ago | washingtonexaminer.com | Gabrielle M. Etzel

Jim O’Neill, President Donald Trump’s nominee for the second-highest position at the Department of Health and Human Services, could usher in policies to encourage anti-aging technologies, shorten approval times for new drugs, and compensate organ donation. O’Neill, a close business associate of venture capitalist and Trump mega donor Peter Thiel, was initially floated to be Trump’s first-term Food and Drug Administration commissioner in 2017, ultimately being passed over for Scott Gottlieb.
NIH begins autism study using Medicare and Medicaid data

1 week ago | washingtonexaminer.com | Gabrielle M. Etzel

Federal public health agencies announced on Wednesday the start of a pilot program to share Medicare and Medicaid data with the National Institutes of Health to tackle chronic diseases, starting with autism. The new partnership between the NIH and the Centers for Medicare and Medicaid Services comes on the heels of Health and Human Services Secretary Robert F.
COVID-19 booster critic tapped to lead FDA vaccine program

1 week ago | washingtonexaminer.com | Gabrielle M. Etzel

Agency commissioner Dr. Marty Makary announced Tuesday that Dr. Vinay Prasad, a prominent COVID–19 vaccine critic, has been appointed to lead the Food and Drug Administration Center, which oversees the approval of vaccines and other biologics products. Prasad, currently a physician-scientist and professor at the University of California, San Francisco, gained a following during the pandemic for criticizing mask mandates, lockdowns, and COVID-19 vaccine boosters.
Trump to freeze funding for research blamed for starting pandemic

1 week ago | washingtonexaminer.com | Gabrielle M. Etzel

President Donald Trump is signed an executive order Monday afternoon to halt federal funding for risky virus research that Republicans argue may have been the cause of the COVID-19 pandemic. The order aims to stop scientists from conducting “gain-of-function” research with federal funding. It will end funding for such research by scientists in countries considered adversaries, such as China and Iran, and pause it in the United States until better safeguards are in place.
Trump proposes 40% cut to NIH over COVID-19 and transgender research

1 week ago | washingtonexaminer.com | Gabrielle M. Etzel

President Donald Trump’s first budget proposal for his second term, released Friday, calls for cutting the National Institutes of Health budget by nearly $18 billion next year, citing the agency’s role in the COVID-19 pandemic and recent transgender medical research as the primary justification for the massive cuts.
Trump 100-day report card: RFK’s MAHA revolution gets mixed grade

1 week ago | washingtonexaminer.com | Gabrielle M. Etzel

The first 100 days of President Donald Trump’s second term has been a whirlwind of activity, punctuated by action at the border, tariffs, turbulent markets, DOGE, multiple lawsuits and constant headlines. This Washington Examiner series “100 Day Report Card” will look at six key issues and how they have come to define the early days of this administration. Part 5 is on the “Make America Healthy Again” movement as executed by Trump’s health and human services secretary, Robert F.
NIH starts $500 million project for universal flu vaccine

1 week ago | washingtonexaminer.com | Gabrielle M. Etzel

A universal flu vaccine could be on the market by the end of the decade, thanks to a new $500 million vaccine program from the National Institutes of Health announced on Thursday. The new initiative from the Health and Human Services Department, called “Generation Gold Standard,” is expected to start clinical trials next year for a universal flu vaccine, which would be meant to protect patients against any strain of the virus.
The Fine Print: Major Trump executive orders that flew under the radar

1 week ago | washingtonexaminer.com | Gabrielle M. Etzel |Naomi Lim

Hours after being sworn in for the start of his second term, President Donald Trump signed a flurry of executive orders aimed at rescinding Biden-era policies and kickstarting his “America First agenda.” On Day One of his presidency, he signed a record 26 executive orders — and this Washington Examiner series, The Fine Print, takes a look at some of those orders that may have flown under the radar, as well as what they mean for the Trump administration and the public.
HHS review says US medical boards failed children with gender dysphoria

1 week ago | washingtonexaminer.com | Gabrielle M. Etzel

U.S. medical professionals and associations have failed children and adolescents struggling with gender dysphoria, the Department of Health and Human Services said in a report released Thursday. The more than 400-page report from the office of HHS Secretary Robert F. Kennedy Jr. comes as a rebuke of the Biden administration’s stance on medical, ethical, and procedural issues related to gender dysphoria for youth, including the support of using puberty blockers, cross-sex hormones, and surgeries.
The Fine Print: Major Trump executive orders that flew under the radar

2 weeks ago | denvergazette.com | Gabrielle M. Etzel |Haisten Willis |Naomi Lim

Hours after being sworn in for the start of his second term, President Donald Trump signed a flurry of executive orders aimed at rescinding Biden-era policies and kickstarting his "America First agenda." On Day One of his presidency, he signed a record 26 executive orders — and this Washington Examiner series, The Fine Print, takes a look at some of those orders that may have flown under the radar, as well as what they mean for the Trump administration and the public.